| Amicus Therapeutics Switzerland GmbH - Opfolda 65 mg, Hartkapseln | | 67806 | | 01 | | Opfolda 65 mg | | Hartkapseln | | A16AX06 | | Miglustat | | 04.07.2024 | | |
| | Composition | | Kapsel: miglustatum 65 mg, cellulosum microcristallinum, maydis amylum, sucralosum, magnesii stearas, silica colloidalis anhydrica, Kapselhülle: gelatina, E 171, E 172 (nigrum), Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 172 (nigrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. | informations additionels |
|---|
| Miglustate | 65 mg | Kapsel |
| | BAG: Principe actif | Concentr. |
|---|
| Miglustate | 65 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Nigrum) | | | | Ammoniae Solutio Concentrata | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Maydis Amylum | | | | Pro Capsula | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | | | Sucralosum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 4 | DDP | DDP | B | | Non | | 002 | 24 | 1005.78 | 1110.25 | B | LS | Non |
|
|
